BME 6230

Cancer and Immuno-Engineering

Course Description

Course information provided by the 2025-2026 Catalog.

Cancer and immunology had been investigated separately for a long time. Recently, they have become connected to each other as we appreciated the roles of immunity in cancer formation, progression, and treatment. As cancer immunotherapies are emerging, understanding of cancer and immunity in deeper manners as a separate topic is required, but also, the abilities to combine both topics in physiologically relevant contexts and relevant knowledge in bioengineering approaches (biomaterials, drug delivery systems, tissue engineering) are needed to be able to solve the multifactorial disease. In this course, we will discuss the topics in Cancer Engineering (module 1); Immune Engineering (module 2); and Cancer Immunotherapy (module 3). In each module, critical biological concepts will be discussed, followed by engineering perspectives, and updated case studies from experts in the cancer and immune-engineering field.

Enrollment Priority Enrollment limited to: graduate students.

Last 1 Terms Offered 2025SP

View Enrollment Information